Three-Pronged attack on lung cancer halted early
NCT ID NCT04619433
Summary
This study tested whether adding two newer drugs (an immunotherapy and a targeted therapy) to standard chemotherapy could better control advanced non-squamous lung cancer. It involved 48 adults with this specific cancer type who had not yet received chemotherapy for their advanced disease. The goal was to see if this combination could slow cancer growth and extend life compared to chemotherapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hosipital
Beijing, Beijing Municipality, 100089, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450003, China
-
Hubei Cancer Hospita
Wuhan, Hubei, 430079, China
-
Shanghai Lung Hospital
Shanghai, Shanghai Municipality, 200433, China
-
Shengjing Hospita of China Medical University
Shenyang, Liaoning, 110022, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, 300060, China
-
West China Hospital，Sichuan University
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.